Preserflo.glaukos.com

Ping response time 16ms Good ping
Domain provide by not available. Domain ID : Not Available
Host name 62.110.229.35.bc.googleusercontent.com, IP address: 35.229.110.62, location: United States

System updated on 2024/12/20

Keyword Suggestion

Preserflo

Preserflo microshunt

Preserflo glaucoma

Preserflo auge

Preserflo implantation

Preserflo mmc

Preserflo santen

Preserflo operation

Preserflo shunt

Preserflo eye

Preserflo surgery

Preserflotm microshunt

Preserflo microshunt surgery

Preserflo microshunt mri safety

Network

Owner

Abuse

Technical support

Domain Provider	Number Of Domains
godaddy.com	286730
namecheap.com	101387
networksolutions.com	69118
tucows.com	52617
publicdomainregistry.com	39120
whois.godaddy.com	32793
enomdomains.com	23825
namesilo.com	21429
domains.google.com	21384
cloudflare.com	20573
gmo.jp	18110
name.com	17601
fastdomain.com	14708
register.com	13495
net.cn	12481
ionos.com	12416
ovh.com	12416
gandi.net	12305
registrar.amazon.com	12111

Host Informations

Check all domain's dns records

See Web Sites Hosted on 35.229.110.62

Fetching Web Sites Hosted

Site Inspections

Loading ...

Port Scanner (IP: 35.229.110.62)

› Ftp: 21

› Ssh: 22

› Telnet: 23

› Smtp: 25

› Dns: 53

› Http: 80

› Pop3: 110

› Portmapper, rpcbind: 111

› Microsoft RPC services: 135

› Netbios: 139

› Imap: 143

› Ldap: 389

› Https: 443

› SMB directly over IP: 445

› Msa-outlook: 587

› IIS, NFS, or listener RFS remote_file_sharing: 1025

› Lotus notes: 1352

› Sql server: 1433

› Point-to-point tunnelling protocol: 1723

› My sql: 3306

› Remote desktop: 3389

› Session Initiation Protocol (SIP): 5060

› Virtual Network Computer display: 5900

› X Window server: 6001

› Webcache: 8080

Spam Check (IP: 35.229.110.62)

› Dnsbl-1.uceprotect.net:

› Dnsbl-2.uceprotect.net:

› Dnsbl-3.uceprotect.net:

› Dnsbl.dronebl.org:

› Dnsbl.sorbs.net:

› Spam.dnsbl.sorbs.net:

› Bl.spamcop.net:

› Recent.dnsbl.sorbs.net:

› All.spamrats.com:

› B.barracudacentral.org:

› Bl.blocklist.de:

› Bl.emailbasura.org:

› Bl.mailspike.org:

› Bl.spamcop.net:

› Cblplus.anti-spam.org.cn:

› Dnsbl.anticaptcha.net:

› Ip.v4bl.org:

› Fnrbl.fast.net:

› Dnsrbl.swinog.ch:

› Mail-abuse.blacklist.jippg.org:

› Singlebl.spamgrouper.com:

› Spam.abuse.ch:

› Spamsources.fabel.dk:

› Virbl.dnsbl.bit.nl:

› Cbl.abuseat.org:

› Dnsbl.justspam.org:

› Zen.spamhaus.org:

Email address with preserflo.glaukos.com

Found 0 emails of this domain

Recent Searched Sites

› Hiropablog.com (1 seconds ago) / JP

› My7475.com (56 seconds ago) / US

› Chawjcreations.com (10 seconds ago) / US

› Jxfz.epbiao.com (24 seconds ago) / CN

› Owenmumford.com (21 seconds ago) / IE

› Jxr.com (18 seconds ago) / SG

› Rclbenziger.com (1 mins ago) / US

› Racekingdom.io (2 seconds ago) / US

› Xscad.com (7 seconds ago) / DE

› Startisrael.co.il (4 seconds ago) / US

› Lompocvmc.net (45 seconds ago) / US

› Online.dws.de (19 seconds ago) / US

› Trelino.com (21 seconds ago) / CA

› Offers-plus.com (14 seconds ago) / US

› K2s-w.com (0 seconds ago) / JP

› 2bmobile.com (15 seconds ago) / US

› S34.jp (36 seconds ago) / JP

› Werner-wiese-3.federatedjournals.com (1 mins ago) / US

› Preserflo.glaukos.com (0 seconds ago) / US

› Juwanhezi.com (59 seconds ago) / CN

List of our tools

Emails by domain

Mobile Friendly Check

Page Speed Check

DNS Lookup

Ports Scan

Sites on host

Sitemap Generator

Websites Listing

We found Websites Listing below when search with preserflo.glaukos.com on Search Engine

PRESERFLO™ MicroShunt: A Simpler Way to Manage Your Glaucoma

Introducing PRESERFLO™ MicroShunt. Introducing the PRESERFLO™ MicroShunt subconjunctival glaucoma drainage device, made from a uniquely biocompatible, degradation-resistant material called SIBS, that is designed to reduce IOP in patients with primary open-angle glaucoma. 5 One end of the PRESERFLO™ MicroShunt is inserted in front of the iris, where …

Preserflo.glaukos.com

PRESERFLO™ MicroShunt: A Simpler Way to Manage Your Glaucoma

PRESERFLO™ MicroShunt is a permanent, less invasive treatment option for the management of glaucoma to help drain excess fluid out of the eye.

Preserflo.glaukos.com

Home | Glaukos

Pioneering New Treatments for Chronic Eye Diseases. At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.

Glaukos.com

Patient Information Brochure - Glaukos

Intended purpose: The PRESERFLO™ MicroShunt & 3mm Scleral Marker is intended for reduction of intraocular pressure in eyes of patients with primary open angle glaucoma where IOP remains uncontrollable while on maximum tolerated medical therapy and/or where glaucoma progression warrants surgery. Special operating instructions for the use of the device: The …

Glaukos.com

Glaukos Expands its PRESERFLO™ MicroShunt Relationship with …

2021-05-18 · Glaukos Expands its PRESERFLO™ MicroShunt Relationship with Santen via New License Agreement. May 18, 2021, 10:00 PM UTC. Share this article. Copied. LIVE ON BLOOMBERG. Watch Live TV Listen to ...

Bloomberg.com

Glaukos - Glaukos Expands its PRESERFLO™ MicroShunt …

Investors.glaukos.com

Glaukos Announces Australia’s TGA Regulatory Approval for …

2022-06-28 · Glaukos Corporation announced that the Therapeutic Goods Administration (TGA) of Australia has granted regulatory approval for the Preserflo MicroShunt intended for the reduction of IOP in eyes of patients with primary open-angle glaucoma where IOP remains uncontrollable while on maximum tolerated medical therapy and/or where glaucoma …

Eyewire.news

Australian TGA approves Glaukos’ PRESERFLO microshunt

2021-06-09 · Glaukos president and CEO Thomas Burns said: “We are delighted to receive regulatory approval from Australia’s TGA for the MicroShunt, marking a notable milestone in advancing our goal to bring this important late-stage glaucoma technology to ophthalmic surgeons and patients. “We believe there is a strong appetite within the global ...

Medicaldevice-network.com

Glaukos Expands its PRESERFLO™ MicroShunt Relationship with

Glaukos Expands its PRESERFLO™ MicroShunt Relationship with Santen via New License Agreement. share: Share on Facebook Tweet on Twitter Post to Reddit. Do NOT follow this link! May 18, 2021 - 6:00 pm ...

Stocktitan.net

Glaukos Expands its PRESERFLO MicroShunt Relationship with …

2021-05-18 · Glaukos launched the iStent ®, its first MIGS device, in the United States in 2012, its next-generation iStent inject ® device in the United States in …

Financialbuzz.com

Glaukos Expands Rights to Distribute Preserflo MicroShunt

2022-06-15 · The Preserflo MicroShunt is an ab-externo drainage system that helps drain eye fluid and reduces intraocular pressure (IOP) in patients with primary open-angle glaucoma whose IOP is not controlled when using maximum tolerated glaucoma medications or where glaucoma progression warrants surgery. IOP reduction is the most effective means of preventing the …

Mivision.com.au

2021-05-18 | NYSE:GKOS | Press Release | GLAUKOS CORPORATION

2021-05-18 · (2021-05-18 | NYSE:GKOS) Glaukos Expands its PRESERFLO(TM) MicroShunt Relationship with Santen via New License Agreement Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies.

Stockhouse.com

Glaukos Announces Australias TGA Regulatory Approval for …

2021-06-08 · Glaukos plans to commence initial commercial launch activities for the MicroShunt in Australia in late 2021, with a full commercial launch targeted in mid-2022 following the establishment of ...

Financialbuzz.com

Australian TGA approves Glaukos’ PRESERFLO microshunt

2021-06-09 · The fins enable fixing of the device in the tissue via a micro-incision and stop leakage or migration. Glaukos president and CEO Thomas Burns said: “We are delighted to receive regulatory approval from Australia’s TGA for the MicroShunt, marking a notable milestone in advancing our goal to bring this important late-stage glaucoma technology to ophthalmic …

Medicaloid.com

Xen and Preserflo: Their Places in the Glaucoma Toolkit

The Preserflo has achieved results comparable to Xen in terms of surgical success, IOP lowering, and safety profile. 7 In the Preserflo patients whom Dr. Lim has followed, she’s noticed a faster recovery and return to comfort than with a trabeculectomy or glaucoma drainage device. And Dr. Blieden added, “Many patients end up on just one drop, which is very reasonable.” …

Aao.org

Stock Market | Markets | Ascensus | www.ascensus.com

2021-05-18 · Glaukos Expands its PRESERFLO™ MicroShunt Relationship with Santen via New License Agreement

Markets.financialcontent.com

Glaukos Expands its Partnership with Santen for Preserflo …

2021-05-19 · Glaukos get exclusive commercialization rights for the MicroShunt in the US- Australia- New Zealand- Canada- Brazil- Mexico and the remainder of Latin America and gain full control over all development activities for the MicroShunt in the same territories- including development and regulatory activities in the US

Pharmashots.com

Glaukos Announces Australia’s TGA Regulatory Approval for …

Glaukos Announces Australia’s TGA Regulatory Approval for PRESERFLO™ MicroShunt; Trending News. LCID. Lucid Starts Production of the Groundbreaking Lucid Air in Arizona; Customer ... DMYI, DMYIU. dMY Technology Group III Stockholders Approve Business Combination with IonQ. GOVX, GOVXW. GeoVax Expands Immuno-Oncology Pipeline with …

Stocktitan.net

Domains Expiration Date Updated

Site	Provider	Expiration Date
passwordrecovery.io	namecheap.com	-2 Years, -296 Days
amicagoldens.com	register.com	5 Years, 150 Days
sabreequipment.com	godaddy.com	-1 Years, -199 Days
smokinghotconfessions.com	godaddy.com	13 Days
sidint.net	networksolutions.com	317 Days
kkwbeauty.com	godaddy.com	-1 Years, -6 Days
kozakaiart.com	netowl.jp	-2 Years, -24 Days
biyouhifuko.com	gmo.jp	3 Years, 253 Days
hxwke.com	net.cn	-1 Years, -265 Days
fansfirst.ca	domainhelp.tucows.com	-2 Years, -189 Days